Corrigendum: Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods
Michael B. VanElzakker, Sydney A. Brumfield, Paula S. Lara Mejia
Abstract
upward linear trend across severity: CCL11, CXCL1, CXCL10, G-CSF, GM-CSF, IFN-γ, IL-4, IL-5, IL-7, IL-12p70, IL-13, IL-17F, leptin, LIF, NGF, SCF, TGF-α resistin in mild and severe groups; significant nonlinear inverted trend: ICAM1, resistin CCL2, CCL3, CCL4, CCL5, CCL7, CD40L, CXCL5, CXCL9, FASL, FGF-basic, HGF, IFN-α, IFN-β, IL-1RA, 1L-1α, IL-1β, IL-2, IL-6, IL-8, IL-10, IL-12p40, IL-15, IL-17, M-CSF, PAI-1, PDGF-BB, TNF-a, TNF-β, TRAIL,IL1β, IL1RA, IL18, IL2, IL4, IL7, IL9, IL13, IL15, IL5, IL6, LIF, IL31, IL10, IL21, IL22, IL12p40, IL12p70, IL23, IL27, IL17A, IL17F
Topics & Concepts
Chronic fatigue syndromeNeuroinflammationEncephalomyelitisMedicineNeurosciencePsychologyImmunologyIntensive care medicinePsychiatryMultiple sclerosisInflammationFibromyalgia and Chronic Fatigue Syndrome ResearchLong-Term Effects of COVID-19